312 related articles for article (PubMed ID: 31600936)
1. Investigating the Multi-Target Pharmacological Mechanism of
Song Y; Wang H; Pan Y; Liu T
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
[No Abstract] [Full Text] [Related]
2. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
Zhang L; Zhang J; Qi B; Jiang G; Liu J; Zhang P; Ma Y; Li W
J Ethnopharmacol; 2016 Nov; 192():132-139. PubMed ID: 27426510
[TBL] [Abstract][Full Text] [Related]
3. Synergistic action of Hedyotis diffusa Willd and Andrographis paniculata in Nasopharyngeal Carcinoma: Downregulating AKT1 and upregulating VEGFA to curb tumorigenesis.
Ye C; Zhang B; Tang Z; Zheng C; Wang Q; Tong X
Int Immunopharmacol; 2024 May; 132():111866. PubMed ID: 38603854
[TBL] [Abstract][Full Text] [Related]
4. Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway.
Lai Z; Yan Z; Chen W; Peng J; Feng J; Li Q; Jin Y; Lin J
Mol Med Rep; 2017 Nov; 16(5):7752-7758. PubMed ID: 28944846
[TBL] [Abstract][Full Text] [Related]
5. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology and experimental validation to identify the potential mechanism of Hedyotis diffusa Willd against rheumatoid arthritis.
Deng H; Jiang J; Zhang S; Wu L; Zhang Q; Sun W
Sci Rep; 2023 Jan; 13(1):1425. PubMed ID: 36697436
[TBL] [Abstract][Full Text] [Related]
7. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway.
Xu X; Chen F; Zhang L; Liu L; Zhang C; Zhang Z; Li W
J Ethnopharmacol; 2021 Oct; 279():114343. PubMed ID: 34147618
[TBL] [Abstract][Full Text] [Related]
8. Systems pharmacology uncover the mechanism of anti-non-small cell lung cancer for Hedyotis diffusa Willd.
Su X; Li Y; Jiang M; Zhu J; Zheng C; Chen X; Zhou J; Li Y; Xiao W; Wang Y
Biomed Pharmacother; 2019 Jan; 109():969-984. PubMed ID: 30551551
[TBL] [Abstract][Full Text] [Related]
9. The protective capability of
Li Y; Ding T; Chen J; Ji J; Wang W; Ding B; Ge W; Fan Y; Xu L
Front Immunol; 2022; 13():943827. PubMed ID: 35958622
[TBL] [Abstract][Full Text] [Related]
10. The anti-inflammatory effects of Hedyotis diffusa Willd on SLE with STAT3 as a key target.
Xu L; Li Y; Ji J; Lai Y; Chen J; Ding T; Li H; Ding B; Ge W
J Ethnopharmacol; 2022 Nov; 298():115597. PubMed ID: 35940466
[TBL] [Abstract][Full Text] [Related]
11. Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms.
Han X; Zhang X; Wang Q; Wang L; Yu S
Biomed Pharmacother; 2020 Oct; 130():110735. PubMed ID: 34321173
[TBL] [Abstract][Full Text] [Related]
12. Hedyotis diffusa Willd extract suppresses Sonic hedgehog signaling leading to the inhibition of colorectal cancer angiogenesis.
Lin J; Wei L; Shen A; Cai Q; Xu W; Li H; Zhan Y; Hong Z; Peng J
Int J Oncol; 2013 Feb; 42(2):651-6. PubMed ID: 23291612
[TBL] [Abstract][Full Text] [Related]
13. Exploring the mechanism of action of Hedyotis diffusa Willd on acne using network analysis.
Seo G; Kim K
Medicine (Baltimore); 2023 Mar; 102(12):e33323. PubMed ID: 36961163
[TBL] [Abstract][Full Text] [Related]
14. Identification of Hedyotis diffusa Willd-specific mRNA-miRNA-lncRNA network in rheumatoid arthritis based on network pharmacology, bioinformatics analysis, and experimental verification.
Jiang J; Huang M; Zhang SS; Wu YG; Li XL; Deng H; Qili XY; Chen JL; Meng Y; Sun WK
Sci Rep; 2024 Mar; 14(1):6291. PubMed ID: 38491124
[TBL] [Abstract][Full Text] [Related]
15. Network Pharmacology-Based Approach to Investigate the Mechanisms of
Liu X; Wu J; Zhang D; Wang K; Duan X; Meng Z; Zhang X
Evid Based Complement Alternat Med; 2018; 2018():7802639. PubMed ID: 29853970
[TBL] [Abstract][Full Text] [Related]
16. The Antitumor Constituents from Hedyotis Diffusa Willd.
Wang C; Zhou X; Wang Y; Wei D; Deng C; Xu X; Xin P; Sun S
Molecules; 2017 Nov; 22(12):. PubMed ID: 29189741
[TBL] [Abstract][Full Text] [Related]
17. Hedyotis diffusa Willd. inhibits VEGF‑C‑mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
Li H; Lai Z; Yang H; Peng J; Chen Y; Lin J
Oncol Rep; 2019 Sep; 42(3):1225-1236. PubMed ID: 31322263
[TBL] [Abstract][Full Text] [Related]
18. Clarification of the phenotypic characteristics and anti-tumor activity of Hedyotis diffusa.
Lee HZ; Bau DT; Kuo CL; Tsai RY; Chen YC; Chang YH
Am J Chin Med; 2011; 39(1):201-13. PubMed ID: 21213409
[TBL] [Abstract][Full Text] [Related]
19. Molecular Targets and Mechanisms of Hedyotis diffusa Willd. for Esophageal Adenocarcinoma Treatment Based on Network Pharmacology and Weighted Gene Co-expression Network Analysis.
Zhuang Y; Sun YG; Wang CG; Zhang Q; Che C; Shao F
Curr Drug Targets; 2024 Jan; ():. PubMed ID: 38213161
[TBL] [Abstract][Full Text] [Related]
20. Extract of Hedyotis diffusa Willd influences murine leukemia WEHI-3 cells in vivo as well as promoting T- and B-cell proliferation in leukemic mice.
Lin CC; Kuo CL; Lee MH; Hsu SC; Huang AC; Tang NY; Lin JP; Yang JS; Lu CC; Chiang JH; Chueh FS; Chung JG
In Vivo; 2011; 25(4):633-40. PubMed ID: 21709007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
